Clinical trials |
Phase |
CTL |
Approve |
Hospital Pt.no |
Remark |
Prophylaxis of EBV/CMV infection after Allogeneic Hemopoietic Stem Cell Transplantation by EBV/CMV Specific Cytotoxic T Lymphocytes |
I/II |
hCMV/EBV-specific CTL |
2004 |
St.Mary’s hospital/2 |
complete |
Prophylaxis of CMV infection after Allogeneic Hemopoietic Stem Cell Transplantation by CMV Specific Cytotoxic T Lymphocytes |
I/II |
hCMV-specific CTL |
2005 |
St.Mary’s hospital/1 |
complete |
Therapy of sustained remission of refractory AML pt. by WT1 Specific Cytotoxic T Lymphocytes |
I/II |
WT1-specific CTL |
2005 |
St.Mary’s hospital/1 |
complete |
For the treatment of hepatocellular carcinoma (HCC) Alpha-fetoprotein (AFP) specific CTLs therapy Recurrence after liver transplantation |
I/II |
AFP-specific CTL |
2006 |
Kangnam St.Mary’s hospital/1 |
complete |
Adoptive immunotherapy using WT1 specific CTLs for high-risk adult acute myeloid leukemia patient |
I/II |
WT1-specific CTL |
2007 |
Seoul St.Mary’s hospital/10 |
complete |
Adoptive Immunotherapy using Epstein-Barr Virus-Specific Cytotoxic T-Lymphocytes for Patients with EBV-Associated Extranodal NK/T cell Lymphoma |
I/II |
EBV-specific CTL |
2007 |
Seoul St.Mary’s hospital/11 |
complete |